BCG VACCINE Powder and solvent for suspension for injection Ref.[27960] Active ingredients: BCG vaccine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: AJ Vaccines A/S, 5 Artillerivej, DK-2300 Copenhagen S, Denmark

Product name and form

BCG Vaccine AJV, powder and solvent for suspension for injection.

Pharmaceutical Form

Powder and solvent for suspension for injection.

White crystalline powder (might be difficult to see due to the small amount of powder in the vial).

The solvent is a colourless solution without any visible particles.

Qualitative and quantitative composition

After reconstitution, 1 dose (0.1 ml) for adults and children aged 12 months and over contains: Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, 2-8 × 105 cfu.

After reconstitution, 1 dose (0.05 ml) for infants under 12 months of age contains: Mycobacterium bovis BCG (Bacillus Calmette-Guerin), Danish strain 1331, live attenuated, 1-4 × 105 cfu.

This is a multidose container. See section 6.5 for the number of doses per vial.

For the full list of excipients, see section 6.1.

Active Ingredient Description
BCG vaccine

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known.

List of Excipients

Powder:

Sodium glutamate

Solvent:

Magnesium sulphate heptahydrate
Dipotassium phosphate
Citric acid monohydrate
L-asparagine monohydrate
Ferric ammonium citrate
Glycerol 85%
Water for injections

Pack sizes and marketing

Powder in amber Type I glass vial with bromobutyl stopper and aluminium cap; 1 ml of solvent in Type I glass vial with a chlorobutyl stopper and an aluminium cap.

Packages of 1, 5, 10 vials and a 1 vial presentation including 1 unidose injection kit (one polypropylene syringe and two injection needles (one long for adding solvent and one short for intradermal injection)).

One vial of reconstituted vaccine contains 1 ml, corresponding to 10 doses for adults and children aged 12 months and over (0.1 ml) or 20 doses for infants under 12 months of age (0.05 ml).

Not all pack sizes may be marketed.

Marketing authorization holder

AJ Vaccines A/S, 5 Artillerivej, DK-2300 Copenhagen S, Denmark

Marketing authorization dates and numbers

PL 46796/0001

Date of first authorisation: 9 September 2002
Date of latest renewal: 26 October 2007

Drugs

Drug Countries
BCG VACCINE AJV Estonia, Finland, France, New Zealand, Poland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.